🇺🇸 E5555 in United States

2 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 2

Most-reported reactions

1. Pain In Extremity — 1 report (50%)
2. Rash — 1 report (50%)

Source database →

Frequently asked questions

Is E5555 approved in United States?

E5555 does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for E5555 in United States?

Eisai Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.